Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1970 1
1971 4
1972 4
1973 4
1974 2
1975 2
1976 3
1978 6
1979 2
1981 1
1983 2
1984 3
1985 3
1986 1
1988 1
1989 2
1990 4
1991 1
1992 1
1993 3
1994 1
1995 1
1996 3
1997 3
1998 4
1999 4
2000 1
2001 1
2002 1
2003 3
2004 5
2005 6
2006 6
2007 1
2008 3
2009 6
2010 12
2011 18
2012 5
2013 10
2014 10
2015 13
2016 15
2017 11
2018 13
2019 13
2020 13
2021 13
2022 11
2023 16
2024 13
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Results by year

Filters applied: . Clear all
Page 1
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.
Peyrl A, Chocholous M, Sabel M, Lassaletta A, Sterba J, Leblond P, Nysom K, Torsvik I, Chi SN, Perwein T, Jones N, Holm S, Nyman P, Mörse H, Öberg A, Weiler-Wichtl L, Leiss U, Haberler C, Schmook MT, Mayr L, Dieckmann K, Kool M, Gojo J, Azizi AA, André N, Kieran M, Slavc I. Peyrl A, et al. Among authors: leblond p. JAMA Oncol. 2023 Dec 1;9(12):1688-1695. doi: 10.1001/jamaoncol.2023.4437. JAMA Oncol. 2023. PMID: 37883081 Free PMC article. Clinical Trial.
Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a "MEMMAT-like" Metronomic Antiangiogenic Approach.
Slavc I, Mayr L, Stepien N, Gojo J, Aliotti Lippolis M, Azizi AA, Chocholous M, Baumgartner A, Hedrich CS, Holm S, Sehested A, Leblond P, Dieckmann K, Haberler C, Czech T, Kool M, Peyrl A. Slavc I, et al. Among authors: leblond p. Cancers (Basel). 2022 Oct 19;14(20):5128. doi: 10.3390/cancers14205128. Cancers (Basel). 2022. PMID: 36291912 Free PMC article.
A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation.
Auffret L, Ajlil Y, Tauziède-Espariat A, Kergrohen T, Puiseux C, Riffaud L, Blouin P, Bertozzi AI, Leblond P, Blomgren K, Froelich S, Picca A, Touat M, Sanson M, Beccaria K, Blauwblomme T, Dangouloff-Ros V, Boddaert N, Varlet P, Debily MA, Grill J, Castel D. Auffret L, et al. Among authors: leblond p. Acta Neuropathol. 2023 Dec 8;147(1):2. doi: 10.1007/s00401-023-02651-4. Acta Neuropathol. 2023. PMID: 38066305 Free PMC article.
Medulloblastoma: Clinical presentation.
Vinchon M, Leblond P. Vinchon M, et al. Among authors: leblond p. Neurochirurgie. 2021 Feb;67(1):23-27. doi: 10.1016/j.neuchi.2019.04.006. Epub 2019 Sep 5. Neurochirurgie. 2021. PMID: 31494131
Bacterial NHEJ: a never ending story.
Bertrand C, Thibessard A, Bruand C, Lecointe F, Leblond P. Bertrand C, et al. Among authors: leblond p. Mol Microbiol. 2019 May;111(5):1139-1151. doi: 10.1111/mmi.14218. Epub 2019 Mar 18. Mol Microbiol. 2019. PMID: 30746801 Free article. Review.
Dynamics of the Streptomyces chromosome: chance and necessity.
Bury-Moné S, Thibessard A, Lioy VS, Leblond P. Bury-Moné S, et al. Among authors: leblond p. Trends Genet. 2023 Nov;39(11):873-887. doi: 10.1016/j.tig.2023.07.008. Epub 2023 Sep 6. Trends Genet. 2023. PMID: 37679290 Review.
Human Radiosensitivity and Radiosusceptibility: What Are the Differences?
El-Nachef L, Al-Choboq J, Restier-Verlet J, Granzotto A, Berthel E, Sonzogni L, Ferlazzo ML, Bouchet A, Leblond P, Combemale P, Pinson S, Bourguignon M, Foray N. El-Nachef L, et al. Among authors: leblond p. Int J Mol Sci. 2021 Jul 2;22(13):7158. doi: 10.3390/ijms22137158. Int J Mol Sci. 2021. PMID: 34281212 Free PMC article. Review.
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study.
Chapman RJ, Ghasemi DR, Andreiuolo F, Zschernack V, Espariat AT, Buttarelli FR, Giangaspero F, Grill J, Haberler C, Paine SML, Scott I, Jacques TS, Sill M, Pfister S, Kilday JP, Leblond P, Massimino M, Witt H, Modena P, Varlet P, Pietsch T, Grundy RG, Pajtler KW, Ritzmann TA. Chapman RJ, et al. Among authors: leblond p. Neuro Oncol. 2023 Oct 3;25(10):1871-1882. doi: 10.1093/neuonc/noad055. Neuro Oncol. 2023. PMID: 36916248 Free PMC article.
BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas.
Huchede P, Meyer S, Berthelot C, Hamadou M, Bertrand-Chapel A, Rakotomalala A, Manceau L, Tomine J, Lespinasse N, Lewandowski P, Cordier-Bussat M, Broutier L, Dutour A, Rochet I, Blay JY, Degletagne C, Attignon V, Montero-Carcaboso A, Le Grand M, Pasquier E, Vasiljevic A, Gilardi-Hebenstreit P, Meignan S, Leblond P, Ribes V, Cosset E, Castets M. Huchede P, et al. Among authors: leblond p. Elife. 2024 Oct 7;12:RP91313. doi: 10.7554/eLife.91313. Elife. 2024. PMID: 39373720 Free PMC article.
255 results